Effect of atrazine, perfluorooctanoic acid and zearalenone on IFNγ, TNFα, and IL-5 mRNA Expression in Jurkat Cells

Biomolecules and Therapeutics

Volumn 18, Issue 3, 2010, Pages 286-293

  Lee, Sung Woo ^a   Son, Hwa Young ^a   Yoon, Won Kee ^b   Jung, Ju Young ^a   Park, Bae Keun ^a   Cho, Eun Sang ^a   Park, Sang Joon ^c   Kim, Tae Hwan ^c   Ryu, Si Yun ^a  

^a Chungnam National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Kyungpook National University   (South Korea)

Author keywords

Atrazine; IFN and gamma; ; IL 5; Perfluorooctanoic acid; TNFa; Zearalenone

Indexed keywords

ATRAZINE; GAMMA INTERFERON; INTERLEUKIN 5; MESSENGER RNA; PERFLUOROOCTANOIC ACID; TUMOR NECROSIS FACTOR ALPHA; ZEARALENONE;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL LINE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ANIMALIA;

EID: 77957352025     PISSN: 19769148     EISSN: None     Source Type: Journal    
DOI: 10.4062/biomolther.2010.18.3.286     Document Type: Article

References (42)

1. Abbas, A. K., Lichtman, A. H. and Pillai, S. (2007). Chapter 12. Cytokines, In Cellular and molecular immunology, pp. 267-273.
2. Saunders Elsevier, Philadelphia. Ahmed, S. A. (2000). The immune system as a potential target for environmental estrogens (endocrine disrupters): a new emerging field. Toxicol. 150, 191-206.
3. Berek, L., Petri, I. B., Mesterházy, Á., Téren, J. and Molnár J. (2001). Effects of mycotoxins on human immune functions in vitro. Toxicol. In Vitro 15, 25-30.
4. Bianchi, M., Bloom, O., Raabe, T., Cohen, P. S., Chesney, J., Sherry, B., Schmidtmayerova, H., Calandra, T., Zhang, X., Bukrinsky, M., Ulrich, P., Cerami, A. and Tracey, K. J. (1996). Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone. J. Exp. Med. 183, 927-936.
5. Bullens, D. M., Van den Keybus, C., Dilissen, E., Kasran, A. and Ceuppens, J. L. (2004). Allergen-specific T cells from birchpollen- allergic patients and healthy controls differ in T helper 2 cytokine and in interleukin-10 production. Clin. Exp. Allergy 34, 879-887.
6. Calemine, J., Zalenka, J., Karpuzoglu-Sahin, E., Ward, D. L., Lengi, A. and Ahmed, S. A. (2003). The immune system of geriatric mice is modulated by estrogenic endocrine disruptors (diethylstilbestrol, y-zearalanol, and genistein): effects on interferon-i. Toxicol. 194, 115-128.
7. Camacho, R., Staruch, M. J., DaSilva, C., Koprak, S., Sewell, T., Salituro, G. and Dumont, F. J. (1999). Hypothemycin inhibits the proliferative response and modulates the production of cytokines during T cell activation. Immunopharmacol. 44, 255-265.
8. Cantemir, C., Cozmei, C., Scutaru, B., Nicoara, S. and Carasevici, E. (1997). p53 protein expression in peripheral lymphocytes from atrazine chronically intoxicated rats. Toxicol. Lett. 93, 87-94.
9. Carruba, G., D'Agostino, P., Miele, M., Calabrò, M., Barbera, C., Di Bella, G., Milano, S., Ferlazzo, V., Caruso, R., La Rosa, M., Cocciadiferro, L., Campisi, I., Castagnetta, L. and Cillari, E. (2003). Estrogen regulates cytokine production and apoptosis in PMA-differentiated, macrophage-like U937 cells. J. Cell Biochem. 90, 187-196.
10. Cetin, Y. and Bullerman, L. B. (2005). Cytotoxicity of Fusarium mycotoxins to mammalian cell cultures as determined by the MTT bioassay. Food Chem. Toxicol. 43, 755-764.
11. Devos, S., De Bosscher, K., Staels, B., Bauer, E., Roels, F., Berghe, W., Haegeman, G., Hooghe, R. and Hooghe-Peters, E. L. (2003). Inhibition of cytokine production by the herbicide atrazine search for nuclear receptor targets. Biochem. Pharmacol. 65, 303-308.
12. Devos, S., Van Den Heuvel, R., Hooghe, R. and Hooghe-Peters, E. L. (2004). Limited effect of selected organic pollutants on cytokine production by peripheral blood leukocytes. Eur. Cytokine Netw. 15, 145-151.
13. Fairley, K. J., Purdy, R., Kearns, S., Anderson, S. E. and Meade, B. J. (2007). Exposure to the immunosuppressant, perfluorooctanoic acid, enhances the murine IgE and airway hypersensitivity response to ovalbumin. Toxicol. Sci. 97, 375-383.
14. Fernandez-Botran, R. and Větvička, V. (1995). Methods in cellular immunology. pp. 6-7. CRC Press, Boca Raton, New York, London, Tokyo.
15. Filipov, N. M., Pinchuk, L. M., Boyd, B. L. and Crittenden, P. L. (2005). Immunotoxic effects of short-term atrazine exposure in young male C57BL/6 mice. Toxicol. Sci. 86, 324-332.
16. Gattoni, A., Parlato, A., Vangieri, B., Bresciani, M. and Derna, R. (2006). Interferon-gamma: biologic functions and HCV therapy (type I/II). Clin. Ter. 157, 377-386.
17. Hooghe, R. J., Devos, S. and Hooghe-Peters, E. L. (2000). Effects of selected herbicides on cytokine production in vitro. Life Sci. 66, 2519-2525.
18. Jensen, A. A. and Leffers, H. (2008). Emerging endocrine disruptors: perfluoroalkylated substances. Int. J. Androl. 31, 161-169.
19. Karpuzoglu, E. and Ahmed, S. A. (2006). Estrogen regulation of nitric oxide and inducible nitric oxide systhase (iNOS) in immune cells: implications for immunity, autoimmune diseases, and apoptosis. Nitric Oxide 15, 177-186.
20. Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A. and Seed, J. (2007). Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol. Sci. 99, 366-394.
21. Lintelmann, J., Katayama, A., Kurihara, N., Shore, L. and Wenzel, A. (2003). Endocrine disruptors in the environment (IUPAC Technical Report). Pure Appl. Chem. 75, 631-681.
22. Lioi, M. B., Santoro, A., Barbieri, R., Salzano, S. and Ursini, M. V. (2004). Ochratoxin A and zearalenone: a comparative study on genotoxic effects and cell death induced in bovine lymphocytes. Mutat. Res. 557, 19-27.
23. Liu, C., Yu, K., Shi, X., Wang, J., Lam, P. K., Wu, R. S. and Zhou, B. (2007). Induction of oxidative stress and apoptosis by PFOA and PFOA in primary cultured hepatocytes of freshwater tilapia (Oreochromis niloticus). Aqua Toxicol. 82, 135-143.
24. Luongo, D., Severino, L., Bergamo, P., De Luna, R., Lucisano, A. and Rossi, M. (2006). Interactive effects of fumonisin B1 and a-zearalenol on proliferation and cytokine expression in Jurkat T cells. Toxicol. In Vitro 20, 1403-1410.
25. Minervini, F., Giannoccaro, A., Cavallini, A. and Visconti, A. (2005). Investigations on cellular proliferation induced by zearalenone and its derivatives in relation to the estrogenic parameters. Toxicol. Lett. 159, 272-283.
26. Nagai, H., Ueda, Y., Tanaka, H., Hirano, Y., Nakamura, N., Inagaki, N., Takatsu, K. and Kawada, K. (1999). Effect of overproduction of interleukin 5 on dinitrofluorobenzeneinduced allergic cutaneous response in mice. J. Pharmacol. Exp. Ther. 288, 43-50.
27. Namazi, M. R. (2004). Cetirizine and allopurinol as novel weapons against cellular autoimmune disorders. Int. Immunopharmacol. 4, 349-353.
28. Odeh, M. (1990). The role of tumor necrosis factor-alpha in acquired immunodeficiency syndrome. J. Intern. Med. 228, 549-556.
29. Ouanes, Z., Ayed-Boussema, I., Baati, T., Creppy, E. E. and Bacha, H. (2005). Zearalenone induces chromosome aberrations in mouse bone marrow: preventive effect of 17i- estradiol, progesterone and vitamin E. Mutat. Res. 565, 139-149.
30. Pruett, S. B., Fan, R., Zheng, Q., Myers, L. P. and Hebert, P. (2003). Modeling and predicting immunological effects of chemical stressors: Characterization of a quantitative biomarker for immunological changes caused by atrazine and ethanol. Toxicol. Sci. 75, 343-354.
31. Rawlins, P., Mander, T., Sadeghi, R., Hill, S., Gammon, G., Foxwell, B., Wrigley, S. and Moore, M. (1999). Inhibition of endotoxin-induced TNF-eeproduction in macrophages by 5Z-7-oxo-zeaenol and other fungal resocylic acid lactones. Int. J. Immunopharmacol. 21, 799-814.
32. Rowe, A. M., Brundage, K. M., Schafer, R. and Barnett, J. B. (2006). Immunomodulatory effects of maternal atrazine exposure on male balb/c mice. Toxicol. Appl. Pharmacol. 214, 69-77.
33. Salem, M. L. (2004). Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. Curr. Drug Targets Inflamm. Allergy 3, 97-104.
34. Takatsu, K., Kouro, T. and Nagai, Y. (2009). Interleukin 5 in the link between the innate and acquired immune response. Adv. Immunol. 101, 191-236.
35. Thurman, E. M. and Cromwell, A. E. (2000). Atmospheric transport, deposition, and fate of triazine herbicides and their metabolites in pristine areas at Isle Royale National Park. Environ. Sci. Technol. 34, 3079-3085.
36. Vlata, Z., Porichis, F., Tzanakakis, G., Tsatsakis, A. and Krambovitis, E. (2006). A study of zearalenone cytotoxicity on human peripheral blood mononuclear cells. Toxicol. Lett. 165, 274-281.
37. Whalen, M. M., Loganathan, B. G., Yamashita, N. and Saito, T. (2003). Immunomodulation of human natural killer cell cytotoxic function by triazine and carbamate pesticides. Chem. Biol. Interact. 145, 311-319.
38. Yang, Q., Abedi-Valugerdi, M., Xie, Y., Zhao, X. Y., Möller, G., Nelson, B. D. and DePoerre, J. W. (2002). Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. Int. Immunopharmacol. 2, 389-397.
39. Yang, Q., Xie, Y. and Depierre, J. W. (2000). Effects of peroxisome proliferators on the thymus and spleen of mice. Clin. Exp. Immunol. 122, 219-226.
40. Yang, Q., Xie, Y., Eriksson, A. M., Nelson, B. D. and DePierre, J. W. (2001). Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice. Biochem. Pharmacol. 61, 1133-1140.
41. Zeljezic, D., Garaj-Vrhovac, V. and Perkovic, P. (2006). Evaluation of DNA damage induced by atrazine and atrazinebased herbicide in human lymphocytes in vitro using a comet and DNA diffusion assay. Toxicol. In Vitro 20, 923-935.
42. Zganiacz, A., Santosuosso, M., Wang, J., Yang, T., Chen, L., Anzulovic, M., Alexander, S., Gicquel, B., Wan, Y., Bramson, J., Inman, M. and Xing, Z. (2004). TNFJJis a critical negative regulators of type 1 immune activation during intracellular bacterial infection. J. Clin. Invest. 113, 401-413.